Literature DB >> 15940032

Tacrolimus and posttransplant diabetes mellitus in renal transplantation.

Johannes P van Hooff1, Maarten H L Christiaans, Elly M van Duijnhoven.   

Abstract

The most prominent side effect of tacrolimus is the induction of posttransplant diabetes mellitus (PTDM). In this review, the authors discuss the incidence, mechanism, prevention, and treatment of tacrolimus-induced PTDM in renal patients.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15940032     DOI： 10.1097/01.tp.0000157870.21957.e5

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


  12 in total

1.  Tacrolimus combined with low-dose corticosteroids is an effective and safe therapeutic option for refractory IgA nephropathy.

Authors:  Qi-Jun Wan; Hao-Fei Hu; Yong-Cheng He; Shao-Dong Luan; Hong-Tao Chen; Tong Li; Yi Xu; Hui-Li Xu; Ying Liao
Journal:  Exp Ther Med       Date:  2016-07-14       Impact factor: 2.447

Review 2.  Post-transplant diabetes mellitus: risk reduction strategies in the elderly.

Authors:  Alain Duclos; Lawrence M Flechner; Charles Faiman; Stuart M Flechner
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

3.  Increasing incidence of new-onset diabetes after transplant among pediatric renal transplant patients.

Authors:  Thomas E Burroughs; Jason P Swindle; Paolo R Salvalaggio; Krista L Lentine; Steven K Takemoto; Suphamai Bunnapradist; Daniel C Brennan; Mark A Schnitzler
Journal:  Transplantation       Date:  2009-08-15       Impact factor: 4.939

4.  Tacrolimus for children with refractory nephrotic syndrome: a one-year prospective, multicenter, and open-label study of Tacrobell®, a generic formula.

Authors:  Eun Mi Yang; Sang Taek Lee; Hyun Jin Choi; Hee Yeon Cho; Joo Hoon Lee; Hee Gyung Kang; Young Seo Park; Hae Il Cheong; Il-Soo Ha
Journal:  World J Pediatr       Date:  2015-12-18       Impact factor: 2.764

5.  Diabetes mellitus increases the risk of mortality following liver transplantation independent of MELD score.

Authors:  Andrew L Samuelson; Maximilian Lee; Ahmad Kamal; Emmet B Keeffe; Aijaz Ahmed
Journal:  Dig Dis Sci       Date:  2010-05-14       Impact factor: 3.199

6.  Long-term impact of pretransplant and posttransplant diabetes mellitus on kidney transplant outcomes.

Authors:  Jen-Pi Tsai; Jong-Da Lian; Sheng-Wen Wu; Tung-Wei Hung; Hui-Ching Tsai; Horng-Rong Chang
Journal:  World J Surg       Date:  2011-12       Impact factor: 3.352

7.  Incidence and relative risk factors in posttransplant diabetes mellitus patients: a retrospective cohort study.

Authors:  Ching-Yao Cheng; Yu-Tung Feng; Hue-Yu Wang
Journal:  Korean J Transplant       Date:  2020-12-16

Review 8.  Calcineurin inhibitor sparing in paediatric solid organ transplantation : managing the efficacy/toxicity conundrum.

Authors:  J Michael Tredger; Nigel W Brown; Anil Dhawan
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 9.  De novo glomerular diseases after renal transplantation.

Authors:  Claudio Ponticelli; Gabriella Moroni; Richard J Glassock
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-03       Impact factor: 8.237

10.  Analysis of common type 2 diabetes mellitus genetic risk factors in new-onset diabetes after transplantation in kidney transplant patients medicated with tacrolimus.

Authors:  Mateusz Kurzawski; Krzysztof Dziewanowski; Joanna Łapczuk; Anna Wajda; Marek Droździk
Journal:  Eur J Clin Pharmacol       Date:  2012-05-09       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.